Physicians Choice Laboratory Services (PCLS) partners with TRICARE South, Humana
May 27, 2015
PCLS is pleased to announce that its esoteric laboratory testing performed at the company’s CLIA-certified and CAP-accredited laboratory will now be available to more than 3 million TRICARE South beneficiaries including active duty service members, retirees and their families in the South Region.
Humana is the administrator of the TRICARE program in the South Region. The TRICARE South Region includes Alabama, Arkansas, Florida, Georgia, the Fort Campbell area of Kentucky, Louisiana, Mississippi, Oklahoma, South Carolina, Tennessee and Texas.
PCLS’s unique mix of services are designed to inform physicians on the patient’s health status relative to several difficult to manage disease states with the goal of improving health outcomes. As an example, PCLS offers advanced laboratory testing aimed at reducing the over-utilization of prescription drugs while aiding doctors in the use of individualized treatment plans that provide better medication outcomes, reduce adverse drug reactions and lower healthcare costs.
PCLS is focused on informing physicians as to how a patient’s genetics can influence drug response which in turn can be used to better titrate a patient to targeted therapeutic levels and minimize adverse reactions. This same dedication to personalized medicine is being applied in all lines of testing services from Women’s Health, to dealing with digestive diseases, to managing risk of heart disease, to recurrence monitoring of bladder cancer.
“Genetics offers a window to better understand the individual aspect of disease – and PCLS is dedicated to improving patient outcomes through advanced diagnostic testing. PCLS believes that the healthcare community understands the importance of early testing and detection in order to improve patient care and drive efficiency throughout the healthcare system,” said Joe Wiegel, CEO and president of PCLS. “We are happy to partner with TRICARE South to ensure that our services are options for more clinicians and patients.”
“Through this collaboration we are pleased to offer our services to TRICARE South, Humana’s 3 million beneficiaries,” added Teri Orsini, PCLS VP of Managed Care.
About Humana
Humana Inc., headquartered in Louisville, KY., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company’s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people we serve across the country.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
- Annual reports to stockholders;
- Securities and Exchange Commission filings;
- Most recent investor conference presentations;
- Quarterly earnings news releases;
- Replays of most recent earnings release conference calls;
- Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors);
- Corporate Governance information
About PCLS
PCLS is an emerging esoteric laboratory that goes beyond testing to provide innovative solutions to healthcare problems. PCLS has a unique mix of services that are designed to inform physicians about their patient’s health status relative to several difficult to manage disease states including narcotic misuse and abuse, neonatal abstinence syndrome, titrating psychiatric drugs for debilitating mental disorders, recurrent/resistant bacterial infections, heart disease, gastrointestinal/urogenital disorders and cancers. The company has broadly invested in offering high value diagnostics that enable personalized and precision medicine to better manage these complicated disease states with the goal of improving health outcomes.
